🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Chemotherapy, such as busulfan, melphalan, and thiotepa, may des...
Status
Completed
Location
Knight Cancer Institute at Oregon Health and Science University
Start Date
2005-03
Trial ID
NCT00238433
The purpose of the study is to find out the effects and the safety of an in...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2010-03
Trial ID
NCT01090973
Treatments Being Tested
RATIONALE: Giving chemotherapy drugs, such as fludarabine and cyclophospham...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2005-07-28
Trial ID
NCT00309842
Subjects are having a bone marrow or SCT for either a type of cancer of the...
Status
Active Not Recruiting
Location
Houston Methodist Hospital
Start Date
2009-04
Trial ID
NCT00840853
Treatments Being Tested
Phase II, multicenter, randomized trial, exploring intensified Rituximab pr...
Status
Completed
Location
Stephane LEPRETRE
Start Date
2011-05
Trial ID
NCT01370772
Treatments Being Tested
The purpose of the study is to investigate whether the combination of ritux...
Status
Completed
Location
UCSD Moores Cancer Center
Start Date
2021-09-02
Trial ID
NCT04981912
Treatments Being Tested
Obatoclax may stop the growth of chronic lymphocytic leukemia by blocking b...
Status
Terminated
Location
Dana-Farber Cancer Institute
Start Date
2008-01
Trial ID
NCT00612612
Treatments Being Tested
This study examines the use of denileukin diftitox (Ontak) for patients wit...
Status
Terminated
Location
Washington University
Start Date
2008-07-01
Trial ID
NCT00632827
Primary Objective: 1\. To determine the maximally tolerated dose of anti-t...
Status
Terminated
Location
U.T.M.D. Anderson Cancer Center
Start Date
2007-05
Trial ID
NCT00473551
The goal of this clinical research study is to learn if adding Zevalin (ibr...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2013-01
Trial ID
NCT01490723